Moreover, recently, DLL1+ cells have been shown to bear similarities to CSCs by showing a high tumor-initiating capacity as well as the ability to drive metastasis and chemoresistance in aggressive luminal breast tumors [20]. This evidence concerns the gene DLL1 and neoplasm.